BN Business News
Add your company to Business Communicator →

Business · 17/11/20261 min read

Opinion/decision on a Paediatric investigation plan (PIP): Hetronifly, serplulimab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: EMA/PE/0000258486

EDITORIAL ILLUSTRATIONBBusinessBN
Illustration generated by Business News; it is not a source photograph.

Summary

Opinion/decision on a Paediatric investigation plan (PIP): Hetronifly, serplulimab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: EMA/PE/0000258486

Original source language: EMA — Paediatric Investigation PlansOpen original release →

Explore insights

Business insights →